Bruker Corp (BRKR)
78.53
-4.41
(-5.32%)
USD |
NASDAQ |
Apr 18, 16:00
78.55
+0.02
(+0.03%)
After-Hours: 20:00
Bruker Enterprise Value: 12.24B for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 12.24B |
| April 16, 2024 | 12.38B |
| April 15, 2024 | 12.63B |
| April 12, 2024 | 12.89B |
| April 11, 2024 | 13.26B |
| April 10, 2024 | 13.02B |
| April 09, 2024 | 13.22B |
| April 08, 2024 | 13.25B |
| April 05, 2024 | 13.28B |
| April 04, 2024 | 13.19B |
| April 03, 2024 | 13.36B |
| April 02, 2024 | 13.34B |
| April 01, 2024 | 13.62B |
| March 28, 2024 | 13.76B |
| March 27, 2024 | 13.75B |
| March 26, 2024 | 13.55B |
| March 25, 2024 | 13.64B |
| March 22, 2024 | 13.76B |
| March 21, 2024 | 13.81B |
| March 20, 2024 | 13.63B |
| March 19, 2024 | 13.50B |
| March 18, 2024 | 13.50B |
| March 15, 2024 | 13.51B |
| March 14, 2024 | 13.47B |
| March 13, 2024 | 13.58B |
| Date | Value |
|---|---|
| March 12, 2024 | 13.59B |
| March 11, 2024 | 13.43B |
| March 08, 2024 | 13.38B |
| March 07, 2024 | 13.52B |
| March 06, 2024 | 13.29B |
| March 05, 2024 | 13.24B |
| March 04, 2024 | 13.23B |
| March 01, 2024 | 12.99B |
| February 29, 2024 | 12.74B |
| February 28, 2024 | 12.74B |
| February 27, 2024 | 12.35B |
| February 26, 2024 | 12.34B |
| February 23, 2024 | 13.12B |
| February 22, 2024 | 12.99B |
| February 21, 2024 | 12.72B |
| February 20, 2024 | 12.60B |
| February 16, 2024 | 12.71B |
| February 15, 2024 | 12.46B |
| February 14, 2024 | 12.45B |
| February 13, 2024 | 11.98B |
| February 12, 2024 | 11.08B |
| February 09, 2024 | 11.06B |
| February 08, 2024 | 11.13B |
| February 07, 2024 | 11.09B |
| February 06, 2024 | 11.55B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.035B
Minimum
Apr 01 2020
13.93B
Maximum
Sep 03 2021
9.517B
Average
9.742B
Median
Mar 07 2022
Enterprise Value Benchmarks
| Azenta Inc | 1.869B |
| Harvard Bioscience Inc | 209.78M |
| Bionano Genomics Inc | 17.87M |
| Akoya Biosciences Inc | 184.27M |
| Singular Genomics Systems Inc | -135.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 205.50M |
| Revenue (Quarterly) | 854.50M |
| Total Expenses (Quarterly) | 721.20M |
| EPS Diluted (Quarterly) | 1.41 |
| Gross Profit Margin (Quarterly) | 50.36% |
| Profit Margin (Quarterly) | 24.05% |
| Earnings Yield | 3.72% |
| Operating Earnings Yield | 4.18% |
| Normalized Earnings Yield | 3.153 |